Eric Topol

Yeah, so to that point, you know, recently a colleague of mine wrote an op-ed in the New York Times about six studies comparing AI alone versus doctors with AI.

And in all six studies, the AI did better than the doctors who had access to AI.

Now, you could interpret that as, well, they don't know how to use AI, they have automation bias, or that is true.

What do you think?

So obviously, you would qualify, you know, there's a spectrum here, the AI enthusiasts, you and I are both in that group.

And then there's the doomsayers.

And there's somewhere middle ground, of course, where people are trying to see the right balance.

Are there concerns about AI enthusiasts?

I mean, anything about that, how it's moving forward that you're worried about?

Do you think that although we've seen what's happening with the current administration,

with respect to the tariffs.

And we already talked about the effects on science funding.

Do you see this as a short-term hit that will eventually prevail?

Do you see them selectively supporting AI efforts?

and finding the right balance with the tech companies to support them and the competition that exists globally with China and whatnot.

How are we going to get forward in what some people consider pretty dark times, which is, of course, so seemingly at odds with the most extraordinary times of human support with AI?

As you've seen, we still have some of these companies in some kind of a hot seat, like Meta and Google, regarding their monopolies.

And we saw how some of the tech leaders, not all, became very supportive.

Potentially, you could interpret that for their own interests, right?

They wanted to give money to the inauguration of